2024
Angiotensin-(1-12): does it exist? A critical evaluation in humans, rats, and mice.
Rodrigues, A.F., Domenig, O., Poglitsch, M., Bader, M. and Danser, A.H.J.
Hypertension 81
(8): 1776-1784.
August 2024
Alternative renin-angiotensin system.
Bader, M., Muscha Steckelings, U., Alenina, N., Santos, R.A.S. and Ferrario, C.M.
Hypertension 81
(5): 964-976.
May 2024
Prospects for leveraging the microbiota as medicine for hypertension.
Durgan, D.J., Zubcevic, J., Vijay-Kumar, M., Yang, T., Manandhar, I., Aryal, S., Muralitharan, R.R., Li, H.B., Li, Y., Abais-Battad, J.M., Pluznick, J.L., Muller, D.N., Marques, F.Z. and Joe, B.
Hypertension 81
(5): 951-963.
May 2024
T- and L-type calcium channels maintain calcium oscillations in the murine zona glomerulosa.
Dinh, H.A., Volkert, M., Secener, A.K., Scholl, U.I. and Stölting, G.
Hypertension 81
(4): 811-822.
April 2024
Sodium as an important regulator of immunometabolism.
Miyauchi, H., Geisberger, S., Luft, F.C., Wilck, N., Stegbauer, J., Wiig, H., Dechend, R., Jantsch, J., Kleinewietfeld, M., Kempa, S. and Mueller, D.N.
Hypertension 81
(3): 426-435.
March 2024
KCNQ5 controls perivascular adipose tissue–mediated vasodilation.
Tsvetkov, D., Schleifenbaum, J., Wang, Y., Kassmann, M., Polovitskaya, M.M., Ali, M., Schütze, S., Rothe, M., Luft, F.C., Jentsch, T.J. and Gollasch, M.
Hypertension 81
(3): 561-571.
March 2024
Tail-cuff versus radiotelemetry to measure blood pressure in mice and rats.
Harrison, D.G., Bader, M., Lerman, L.O., Fink, G., Karumanchi, S.A., Reckelhoff, J.F., Sequeira-Lopez, M.L.S. and Touyz, R.M.
Hypertension 81
(1): 3-5.
January 2024
2023
Mutations in phosphodiesterase 3A (PDE3A) cause hypertension without cardiac damage.
Ercu, M., Walter, S. and Klussmann, E.
Hypertension 80
(6): 1171-1179.
June 2023
Studies in zebrafish and rat models support dual blockade of EP2 and EP4 (prostaglandin E(2) receptors type 2 and 4) for renoprotection in glomerular hyperfiltration and albuminuria.
Kourpa, A., Schulz, A., Mangelsen, E., Kaiser-Graf, D., Koppers, N., Stoll, M., Rothe, M., Bader, M., Purfürst, B., Kunz, S., Gladytz, T., Niendorf, T., Bachmann, S., Mutig, K., Bolbrinker, J., Panakova, D. and Kreutz, R.
Hypertension 80
(4): 771-782.
April 2023
2022
Quantitative phosphoproteomics of the angiotensin AT(2)-receptor signaling network identifies HDAC1 (Histone-Deacetylase-1) and p53 as mediators of antiproliferation and apoptosis.
Peluso, A.A.B., Kempf, S.J., Verano-Braga, T., Rodrigues-Ribeiro, L., Johansen, L.E., Hansen, M.R., Kitlen, G., Haugaard, A.H., Sumners, C., Ditzel, H.J., Santos, R.A., Bader, M., Larsen, M.R. and Steckelings, U.M.
Hypertension 79
(11): 2530-2541.
November 2022
Genetic engineering of lymphangiogenesis in skin does not affect blood pressure in mouse models of salt-sensitive hypertension.
Thowsen, I.M., Reikvam, T., Skogstrand, T., Samuelsson, A.M., Mueller, D.N., Tenstad, O., Alitalo, K., Karlsen, T. and Wiig, H.
Hypertension 79
(11): 2451-2462.
November 2022
Loss of endothelial cytochrome P450 reductase induces vascular dysfunction in mice.
Malacarne, P.F., Ratiu, C., Gajos-Draus, A., Müller, N., Lopez, M., Pflüger-Müller, B., Ding, X., Warwick, T., Oo, J., Siragusa, M., Angioni, C., Günther, S., Weigert, A., Geißlinger, G., Lütjohann, D., Schunck, W.H., Fleming, I., Brandes, R.P. and Rezende, F.
Hypertension 79
(6): 1216-1226.
June 2022
Effect of sunitinib treatment on skin sodium accumulation in patients with renal cancer: a pilot study.
Markó, L., Dörr, A., Linz, P., van den Meiracker, A.H., Garrelds, I.M., Kuehne, T., Dechend, R., Danser, A.H.J., Flörcken, A. and Müller, D.N.
Hypertension 79
(5): e103-e105.
May 2022
Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association.
Garovic, V.D., Dechend, R., Easterling, T., Karumanchi, S.A., McMurtry Baird, S., Magee, L.A., Rana, S., Vermunt, J.V. and August, P.
Hypertension 79
(2): e21-e41.
February 2022
2021
Circulating maternal sFLT1 (soluble fms-like tyrosine kinase-1) is sufficient to impair spiral arterial remodeling in a preeclampsia mouse model.
Vogtmann, R., Heupel, J., Herse, F., Matin, M., Hagmann, H., Bendix, I., Kräker, K., Dechend, R., Winterhager, E., Kimmig, R., Köninger, A. and Gellhaus, A.
Hypertension 78
(4): 1067-1079.
September 2021
Maternal angiotensin increases placental leptin in early gestation via an alternative renin-angiotensin system pathway: suggesting a link to preeclampsia.
Nonn, O., Fischer, C., Geisberger, S., El-Heliebi, A., Kroneis, T., Forstner, D., Desoye, G., Staff, A.C., Sugulle, M., Dechend, R., Pecks, U., Kollmann, M., Stern, C., Cartwright, J.E., Whitley, G.S., Thilaganathan, B., Wadsack, C., Huppertz, B., Herse, F. and Gauster, M.
Hypertension 77
(5): 1723-1736.
May 2021
Can single nucleotide polymorphisms beat Schnüffel? Assessing hypertension polygenic risk scores.
Luft, F.C.
Hypertension 77
(4): 1128-1132.
April 2021
Intrauterine exposure to diabetic milieu does not induce diabetes and obesity in male adulthood in a novel rat model.
Schütte, T., Kedziora, S.M., Haase, N., Herse, F., Busjahn, A., Birukov, A., Alenina, N., Müller, D.N., Bader, M., Schupp, M., Dechend, R., Kräker, K. and Golic, M.
Hypertension 77
(1): 202-215.
January 2021
2020
Will postnatal renin-angiotensin system blockade improve long-term maternal cardiovascular health after preeclampsia?
Staff, A.C. and Dechend, R.
Hypertension 76
(6): 1704-1706.
December 2020
Proteomic analysis reveals upregulation of ACE2, the putative SARS-CoV-2 receptor in pressure- but not volume-overloaded human hearts.
Stegbauer, J., Kraus, M., Nordmeyer, S., Kirchner, M., Ziehm, M., Dommisch, H., Kelle, S., Kelm, M., Baczko, I., Landmesser, U., Tschope, C., Knosalla, C., Falcke, M., Schapranow, M.P., Regitz-Zagrosek, V., Mertins, P. and Kuehne, T.
Hypertension 76
(6): e41-e43.
December 2020
Blood pressure and angiogenic markers in pregnancy: contributors to pregnancy-induced hypertension and offspring cardiovascular risk.
Birukov, A.., Herse, F., Nielsen, J.H., Kyhl, H.B., Golic, M., Kräker, K., Haase, N., Busjahn, A., Bruun, S., Jensen, B.L., Müller, D.N., Jensen, T.K., Christesen, H.T., Andersen, M.S., Jørgensen, J.S., Dechend, R. and Andersen, L.B.
Hypertension 76
(3): 901-909.
September 2020
Norman M. Kaplan: January 2, 1931-April 5, 2020.
Townsend, R.R., DiPette, D.J., Luft, F.C., Weinberger, M.H. and Ram, V.
Hypertension 76
(2): 291-293.
August 2020
Multiplex analysis of circulating maternal cardiovascular biomarkers comparing preeclampsia subtypes.
Lekva, T., Sugulle, M., Moe, K., Redman, C., Dechend, R. and Staff, A.C.
Hypertension 75
(6): 1513-1522.
June 2020
Statins reverse postpartum cardiovascular dysfunction in a rat model of preeclampsia.
Kräker, K., O'Driscoll, J.M., Schütte, T., Herse, F., Patey, O., Golic, M., Geisberger, S., Verlohren, S., Birukov, A., Heuser, A., Mueller, D.N., Thilaganathan, B., Dechend, R. and Haase, N.
Hypertension 75
(1): 202-210.
January 2020
Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent.
Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J.A. and Batlle, D.
Hypertension 75
(1): 173-182.
January 2020
2019
Aldosterone, salt, and potassium intakes as predictors of pregnancy outcome, including preeclampsia.
Birukov, A., Andersen, L.B., Herse, F., Rakova, N., Kitlen, G., Kyhl, H.B., Golic, M., Haase, N., Kräker, K., Müller, D.N., Jørgensen, J.S., Andersen, M.S., Dechend, R. and Jensen, B.L.
Hypertension 74
(2): 391-398.
August 2019
Urinary renin in patients and mice with diabetic kidney disease.
Tang, J., Wysocki, J., Ye, M., Vallés, P.G., Rein, J., Shirazi, M., Bader, M., Gomez, R.A., Sequeira-Lopez, M.L.S., Afkarian, M. and Batlle, D.
Hypertension 74
(1): 83-94.
July 2019
Precarious symbiosis between host and microbiome in cardiovascular health.
Bartolomaeus, H., Markó, L., Wilck, N., Luft, F.C., Forslund, S.K. and Muller, D.N.
Hypertension 73
(5): 926-935.
May 2019
2018
The Meaning of Mas.
Bader, M., Alenina, N., Young, D., Santos, R.A.S. and Touyz, R.M.
Hypertension 72
(5): 1072-1075.
November 2018
Classical cardiovascular risk markers in pregnancy and associations to uteroplacental acute atherosis.
Moe, K., Alnaes-Katjavivi, P., Storvold, G.L., Sugulle, M., Johnsen, G.M., Redman, C.W.G., Dechend, R. and Staff, A.C.S.
Hypertension 72
(3): 695-702.
September 2018
Renin-angiotensin system in aortic aneurysm: still adding puzzle stones to an anything but complete picture.
Steckelings, U.M. and Bader, M.
Hypertension 72
(3): 579-581.
September 2018
Can we end the salt wars with a randomized clinical trial in a controlled environment?
Jones, D.W., Luft, F.C., Whelton, P.K., Alderman, M.H., Hall, J.E., Peterson, E.D., Califf, R.M. and McCarron, D.A.
Hypertension 72
(1): 10-11.
July 2018
Modeling superimposed preeclampsia using Ang II (Angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats.
Morgan, H.L., Butler, E., Ritchie, S., Herse, F., Dechend, R., Beattie, E., McBride, M.W. and Graham, D.
Hypertension 72
(1): 208-218.
July 2018
Preeclampsia: What does the brain tell us? Can we blame the eclampsia risk on a malperfused placenta?
Staff, A.C. and Dechend, R.
Hypertension 72
(1): 65-67.
July 2018
Salt, blood pressure, and aldosterone in women and men.
Luft, F.C.
Hypertension 71
(6): 1026-1027.
June 2018
Cystathionine γ-lyase-produced hydrogen sulfide controls endothelial NO bioavailability and blood pressure.
Szijártó, I.A., Markó, L., Filipovic, M.R., Miljkovic, J.L., Tabeling, C., Tsvetkov, D., Wang, N., Rabelo, L.A., Witzenrath, M., Diedrich, A., Tank, J., Akahoshi, N., Kamata, S., Ishii, I. and Gollasch, M.
Hypertension 71
(6): 1210-1217.
June 2018
Diabetes mellitus in pregnancy leads to growth restriction and epigenetic modification of the Srebf2 gene in rat fetuses.
Golic, M., Stojanovska, V., Bendix, I., Wehner, A., Herse, F., Haase, N., Kräker, K., Fischer, C., Alenina, N., Bader, M., Schütte, T., Schuchardt, M., van der Giet, M., Henrich, W., Muller, D.N., Felderhoff-Müser, U., Scherjon, S., Plösch, T. and Dechend, R.
Hypertension 71
(5): 911-920.
May 2018
Akap1 regulates vascular function and endothelial cells behavior.
Schiattarella, G.G., Cattaneo, F., Carrizzo, A., Paolillo, R., Boccella, N., Ambrosio, M., Pironti, G., Damato, A., Franzone, A., Russo, G., Magliulo, F., Pirozzi, M., Storto, M., Madonna, M., Gargiulo, G., Trimarco, V., Rinaldi, L., De Lucia, M., Garbi, C., Feliciello, A., Esposito, G., Vecchione, C. and Perrino, C.
Hypertension 71
(3): 507-517.
March 2018
2017
Of mice and renin.
Bader, M.
Hypertension 70
(1): 35-37.
July 2017
Evidence for heterodimerization and functional interaction of the angiotensin Type 2 receptor and the receptor MAS.
Leonhardt, J., Villela, D.C., Teichmann, A., Münter, L.-M., Mayer, M.C., Mardahl, M., Kirsch, S., Namsolleck, P., Lucht, K., Benz, V., Alenina, N., Daniell, N., Horiuchi, M., Iwai, M., Multhaup, G., Schülein, R., Bader, M., Santos, R.A., Unger, T. and Steckelings, U.M.
Hypertension 69
(6): 1128-1135.
June 2017
Downregulation of Plzf gene ameliorates metabolic and cardiac traits in the spontaneously hypertensive rat.
Liška, F., Landa, V., Zidek, V., Mlejnek, P., Šilhavý, J., Šimáková, M., Strnad, H., Trnovská, J., Škop, V., Kazdová, L., Starker, C.G., Voytas, D.F., Izsvák, Z., Mancini, M., Šeda, O., Křen, V. and Pravenec, M.
Hypertension 69
(6): 1084-1091.
June 2017
Brain renin-angiotensin system: does it exist?
van Thiel, B.S., Góes Martini, A., Te Riet, L., Severs, D., Uijl, E., Garrelds, I.M., Leijten, F.P.J., van der Pluijm, I., Essers, J., Qadri, F., Alenina, N., Bader, M., Paulis, L., Rajkovicova, R., Domenig, O., Poglitsch, M. and Danser, A.H.J.
Hypertension 69
(6): 1136-1144.
June 2017
Salt sensitivity of angiogenesis inhibition-induced blood pressure rise: role of interstitial sodium accumulation?
Lankhorst, S., Severs, D., Markó, L., Rakova, N., Titze, J., Müller, D.N., Danser, A.H.J. and van den Meiracker, A.H.
Hypertension 69
(5): 919-926.
May 2017
High-salt diet causes osmotic gradients and hyperosmolality in skin without affecting interstitial fluid and lymph.
Nikpey, E., Karlsen, T.V., Rakova, N., Titze, J.M., Tenstad, O. and Wiig, H.
Hypertension 69
(4): 660-668.
April 2017
2016
Agonistic autoantibodies to the angiotensin II type 1 receptor enhance angiotensin II-induced renal vascular sensitivity and reduce renal function during pregnancy.
Cunningham, M.W., Williams, J.M., Amaral, L., Usry, N., Wallukat, G., Dechend, R. and LaMarca, B.
Hypertension 68
(5): 1308-1313.
November 2016
Tumor necrosis factor-α, uterine natural killer cells, and pregnancy.
Golic, M., Luft, F.C. and Dechend, R.
Hypertension 68
(5): 1108-1109.
November 2016
Natural killer cell reduction and uteroplacental vasculopathy.
Golic, M., Haase, N., Herse, F., Wehner, A., Vercruysse, L., Pijnenborg, R., Balogh, A., Saether, P.C., Dissen, E., Luft, F.C., Przybyl, L., Park, J.K., Alnaes-Katjavivi, P., Staff, A.C., Verlohren, S., Henrich, W., Muller, D.N. and Dechend, R.
Hypertension 68
(4): 964-973.
October 2016
Identification of serum metabolites associated with incident hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
Dietrich, S., Floegel, A., Weikert, C., Pischon, T., Boeing, H. and Drogan, D.
Hypertension 68
(2): 471-477.
August 2016
Physiology unmasks hypertension.
Heusser, K., Brinkmann, J., Topalidis, W., Menne, J., Haller, H., Berliner, D.., Luft, F.C., Tank, J. and Jordan, J.
Hypertension 68
(2): 252-256.
August 2016
Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects.
Laffer, C.L., Scott, R.C., Titze, J.M., Luft, F.C. and Elijovich, F.
Hypertension 68
(1): 195-203.
July 2016
2015
Agreement between 24-hour salt ingestion and sodium excretion in a controlled environment.
Lerchl, K., Rakova, N., Dahlmann, A., Rauh, M., Goller, U., Basner, M., Dinges, D.F., Beck, L., Agureev, A., Larina, I., Baranov, V., Morukov, B., Eckardt, K.U., Vassilieva, G., Wabel, P., Vienken, J., Kirsch, K., Johannes, B., Krannich, A., Luft, F.C. and Titze, J.
Hypertension 66
(4): 850-857.
October 2015
Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly.
Toka, O., Tank, J., Schächterle, C., Aydin, A., Maass, P.G., Elitok, S., Bartels-Klein, E., Hollfinger, I., Lindschau, C., Mai, K., Boschmann, M., Rahn, G., Movsesian, M.A., Müller, T., Doescher, A., Gnoth, S., Mühl, A., Toka, H.R., Wefeld-Neuenfeld, Y., Utz, W., Töpper, A., Jordan, J., Schulz-Menger, J., Klussmann, E., Bähring, S. and Luft, F.C.
Hypertension 66
(4): 800-808.
October 2015
Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsia.
Przybyl, L., Ibrahim, T., Haase, N., Golic, M., Rugor, J., Luft, F.C., Bendix, I., Serdar, M., Wallukat, G., Staff, A.C., Müller, D.N., Hünig, T., Felderhoff-Müser, U., Herse, F., LaMarca, B. and Dechend, R.
Hypertension 65
(6): 1298-1306.
June 2015
2014
Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
Cardin, S., Scott-Boyer, M.P., Praktiknjo, S., Jeidane, S., Picard, S., Reudelhuber, T.L. and Deschepper, C.F.
Hypertension 64
(5): 1040-1046.
November 2014
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.
Markó, L., Henke, N., Park, J.K., Spallek, B., Qadri, F., Balogh, A., Apel, I.J., Oravecz-Wilson, K.I., Choi, M., Przybyl, L., Binger, K.J., Haase, N., Wilck, N., Heuser, A., Fokuhl, V., Ruland, J., Lucas, P.C., McAllister-Lucas, L.M., Luft, F.C., Dechend, R. and Müller, D.N.
Hypertension 64
(5): 1032-1039.
November 2014
Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels.
Schmieder, R.E., Schmidt, S.T., Riemer, T., Dechend, R., Hagedorn, I., Senges, J., Messerli, F.H. and Zeymer, U.
Hypertension 64
(5): 1067-1072.
November 2014
Who and what drove Walter Kempner? The rice diet revisited.
Klemmer, P., Grim, C.E. and Luft, F.C.
Hypertension 64
(4): 684-688.
October 2014
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.
Pulgar, V.M., Yamaleyeva, L.M., Varagic, J., McGee, C.M., Bader, M., Dechend, R., Howlett, A.C. and Brosnihan, K.B.
Hypertension 64
(3): 619-625.
September 2014
Sodium shows no mercy on the nanomechanics of endothelial cells.
Luft, F.C.
Hypertension 64
(2): 231-232.
August 2014
Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice.
Pena Silva, R.A., Kung, D.K., Mitchell, I.J., Alenina, N., Bader, M., Santos, R.A.S., Faraci, F.M., Heistad, D.D. and Hasan, D.M.
Hypertension 64
(2): 362-368.
August 2014
2013
Administration of interleukin-17 soluble receptor C suppresses T(H)17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy.
Cornelius, D.C., Hogg, J.P., Scott, J., Wallace, K., Herse, F., Moseley, J., Wallukat, G., Dechend, R. and Lamarca, B.
Hypertension 62
(6): 1068-1073.
December 2013
KCNQ channels and novel insights into coronary perfusion.
Gollasch, M.
Hypertension 62
(6): 1011-1012.
December 2013
Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
Brewer, J., Liu, R., Lu, Y., Scott, J., Wallace, K., Wallukat, G., Moseley, J., Herse, F., Dechend, R., Martin, J.N. and Lamarca, B.
Hypertension 62
(5): 886-892.
November 2013
Amyloid-β peptides activate α1-adrenergic cardiovascular receptors.
Haase, N., Herse, F., Spallek, B., Haase, H., Morano, I., Qadri, F., Szijártó, I.A., Rohm, I., Yilmaz, A., Warrington, J.P., Ryan, M.J., Gollasch, M., Müller, D.N., Dechend, R. and Wallukat, G.
Hypertension 62
(5): 966-972.
November 2013
miR-30a regulates endothelial tip cell formation and arteriolar branching.
Jiang, Q., Lagos-Quintana, M., Liu, D., Shi, Y., Helker, C., Herzog, W. and le Noble, F.
Hypertension 62
(3): 592-598.
September 2013
Truly refractory hypertension.
Schroeder, C., Heusser, K., Brinkmann, J., Menne, J., Oswald, H., Haller, H., Jordan, J., Tank, J. and Luft, F.C.
Hypertension 62
(2): 231-235.
August 2013
Two genomic regions of chromosomes 1 and 18 explain most of the stroke susceptibility under salt loading in stroke-prone spontaneously hypertensive Rat/Izm.
Gandolgor, T.A., Ohara, H., Cui, Z.H., Hirashima, T., Ogawa, T., Saar, K., Hübner, N., Watanabe, T., Isomura, M. and Nabika, T.
Hypertension 62
(1): 55-61.
July 2013
Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model.
Gürgen, D., Kusch, A., Klewitz, R., Hoff, U., Catar, R., Hegner, B., Kintscher, U., Luft, F.C. and Dragun, D.
Hypertension 61
(3): 730-736.
March 2013
(23)Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients.
Kopp, C., Linz, P., Dahlmann, A., Hammon, M., Jantsch, J., Müller, D.N., Schmieder, R.E., Cavallaro, A., Eckardt, K.U., Uder, M., Luft, F.C. and Titze, J.
Hypertension 61
(3): 635-640.
March 2013
Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia.
Kvehaugen, A.S., Melien, O., Holmen, O.L., Laivuori, H., Oian, P., Andersgaard, A.B., Dechend, R. and Staff, A.C.
Hypertension 61
(3): 655-661.
March 2013
Aldosterone modulates endothelial permeability and endothelial nitric oxide synthase activity by rearrangement of the actin cytoskeleton.
Kirsch, T., Beese, M., Wyss, K., Klinge, U., Haller, H., Haubitz, M. and Fiebeler, A.
Hypertension 61
(2): 501-508.
February 2013
Functional cross-talk between aldosterone and angiotensin-(1-7) in ventricular myocytes.
Machado de Almeida, P.W., de Freitas Lima, R., de Morais Gomes, E.R., Rocha-Resende, C., Roman-Campos, D., Gondim, A.N.S., Gavioli, M., Lara, A., Parreira, A., de Azevedo Nunes, S.L., Alves, M.N.M., Lauton Santos, S., Alenina, N., Bader, M., Ribeiro Resende, R., dos Santos Cruz, J., Souza dos Santos, R.A. and Guatimosim, S.
Hypertension 61
(2): 425-430.
February 2013
Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy.
Schreier, B., Rabe, S., Schneider, B., Bretschneider, M., Rupp, S., Ruhs, S., Neumann, J., Rueckschloss, U., Sibilia, M., Gotthardt, M., Grossmann, C. and Gekle, M.
Hypertension 61
(2): 333-340.
February 2013
Increased proliferative cells in the medullary thick ascending limb of the loop of henle in the dahl salt-sensitive rat.
Yang, C., Stingo, F.C., Ahn, K.W., Liu, P., Vannucci, M., Laud, P.W., Skelton, M., O’Connor, P., Kurth, T., Ryan, R.P., Moreno, C., Tsaih, S.W., Patone, G., Hummel, O., Jacob, H.J., Liang, M. and Cowley, A.W.
Hypertension 61
(1): 208-215.
January 2013
Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction.
Zavaritskaya, O., Zhuravleva, N., Schleifenbaum, J., Gloe, T., Devermann, L., Kluge, R., Mladenov, M., Frey, M., Gagov, H., Fesues, G., Gollasch, M. and Schubert, R.
Hypertension 61
(1): 151-159.
January 2013
2012
Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage.
Marko, L., Kvakan, H., Park, J.K., Qadri, F., Spallek, B., Binger, K.J., Bowman, E.P., Kleinewietfeld, M., Fokuhl, V., Dechend, R. and Mueller, D.N.
Hypertension 60
(6): 1430-1436.
December 2012
CD19+CD5+ cells as indicators of preeclampsia.
Jensen, F., Wallukat, G., Herse, F., Budner, O., El-Mousleh, T., Costa, S.D., Dechend, R. and Zenclussen, A.C.
Hypertension 59
(4): 861-868.
April 2012
Placenta messages to the mother: not just debris.
Dechend, R. and Staff, A.C.
Hypertension 59
(2): 191-193.
February 2012
Severe hypertension with large-vessel arteritis.
Kettritz, R. and Luft, F.C.
Hypertension 59
(2): 179-183.
February 2012
Adrenergic cardiovascular control before and after removal of stimulatory alpha-1 adrenoreceptor antibodies.
Schroeder, C., Stabroth, C., Luft, F.C. and Jordan, J.
Hypertension 59
(2): e6-e7.
February 2012
Cardiovascular biomarker midregional proatrial natriuretic peptide during and after preeclamptic pregnancies.
Sugulle, M., Herse, F., Hering, L., Mockel, M., Dechend, R. and Staff, A.C.
Hypertension 59
(2): 395-401.
February 2012
Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects.
Haufe, S., Utz, W., Engeli, S., Kast, P., Boehnke, J., Pofahl, M., Traber, J., Haas, V., Hermsdorf, M., Mähler, A., Busjahn, A., Wiesner, S., Otto, C., Mehling, H., Luft, F.C., Boschmann, M., Schulz-Menger, J. and Jordan, J.
Hypertension 59
(1): 70-75.
January 2012
23Na magnetic resonance imaging of tissue sodium.
Kopp, C., Linz, P., Wachsmuth, L., Dahlmann, A., Horbach, T., Schoefl, C., Renz, W., Santoro, D., Niendorf, T., Mueller, D.N., Neininger, M., Cavallaro, A., Eckardt, K.U., Schmieder, R.E., Luft, F.C., Uder, M. and Titze, J.
Hypertension 59
(1): 167-172.
January 2012
Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
Finckenberg, P., Eriksson, O., Baumann, M., Merasto, S., Lalowski, M.M., Levijoki, J., Haasio, K., Kytoe, V., Mueller, D.N., Luft, F.C., Oresic, M. and Mervaala, E.
Hypertension 59
(1): 76-84.
2012
2011
Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur?
Batenburg, W.W., Lu, X., Leijten, F., Maschke, U., Mueller, D.N. and Danser, A.H.J.
Hypertension 58
(6): 1111-1119.
December 2011
Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokine.
Herse, F., Fain, J.N., Janke, J., Engeli, S., Kuhn, C., Frey, N., Weich, H.A., Bergmann, A., Kappert, K., Karumanchi, S.A., Luft, F.C., Mueller, D.N., Staff, A.C. and Dechend, R.
Hypertension 58
(1): 37-42.
July 2011
Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia.
Kvehaugen, A.S., Dechend, R., Ramstad, H.B., Troisi, R., Fugelseth, D. and Staff, A.C.
Hypertension 58
(1): 63-69.
July 2011
Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats.
Wenzel, K., Rajakumar, A., Haase, H., Geusens, N., Hubner, N., Schulz, H., Brewer, J., Roberts, L., Hubel, C.A., Herse, F., Hering, L., Qadri, F., Lindschau, C., Wallukat, G., Pijnenborg, R., Heidecke, H., Riemekasten, G., Luft, F.C., Muller, D.N., Lamarca, B. and Dechend, R.
Hypertension 58
(1): 77-84.
July 2011
Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling.
Guimaraes, P.B., Alvarenga, E.C., Siqueira, P.D., Paredes-Gamero, E.J., Sabatini, R.A., Morais, R.L., Reis, R.I., Santos, E.L., Teixeira, L.G., Casarini, D.E., Martin, R.P., Shimuta, S.I., Carmona, A.K., Nakaie, C.R., Jasiulionis, M.G., Ferreira, A.T., Pesquero, J.L., Oliveira, S.M., Bader, M., Costa-Neto, C.M. and Pesquero, J.B.
Hypertension 57
(5): 965-972.
May 2011
Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.
Lamarca, B., Wallace, K., Herse, F., Wallukat, G., Martin, J.N., Weimer, A. and Dechend, R.
Hypertension 57
(4): 865-871.
April 2011
Estrogen receptor-β signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice.
Gürgen, D., Hegner, B., Kusch, A., Catar, R., Chaykovska, L., Hoff, U., Gross, V., Slowinski, T., da Costa Goncalves, A.C., Kintscher, U., Gustafsson, J.A., Luft, F.C. and Dragun, D.
Hypertension 57
(3): 648-654.
March 2011
2010
Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health.
Staff, A.C., Dechend, R. and Pijnenborg, R.
Hypertension 56
(6): 1026-1034.
December 2010
Childhood hypertension in autosomal-dominant hypertension with brachydactyly.
Toka, O., Maass, P.G., Aydin, A., Toka, H., Huebner, N., Rueschendorf, F., Gong, M., Luft, F.C. and Bähring, S.
Hypertension 56
(5): 988-994.
November 2010
Effects of circulating and local uteroplacental angiotensin II in rat pregnancy.
Hering, L., Herse, F., Geusens, N., Verlohren, S., Wenzel, K., Staff, A.C., Brosnihan, K.B., Huppertz, B., Luft, F.C., Mueller, D.N., Pijnenborg, R., Cartwright, J.E. and Dechend, R.
Hypertension 56
(2): 311-318.
August 2010
Response to Blood pressure control: a facelift for macrophages?
Titze, J., Mueller, D.N. and Luft, F.C.
Hypertension 56
(2): E24.
August 2010
Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy.
Verlohren, S., Geusens, N., Morton, J., Verhaegen, I., Hering, L., Herse, F., Dudenhausen, J.W., Mueller, D.N., Luft, F.C., Cartwright, J.E., Davidge, S.T., Pijnenborg, R. and Dechend, R.
Hypertension 56
(2): 304-310.
August 2010
Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the Mas receptor.
Savergnini, S.Q., Beiman, M., Lautner, R.Q., de Paula-Carvalho, V., Allahdadi, K., Pessoa, D.C., Costa-Fraga, F.P., Fraga-Silva, R.A., Cojocaru, G., Cohen, Y., Bader, M., de Almeida, A.P., Rotman, G. and Santos, R.A.
Hypertension 56
(1): 112-120.
July 2010
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor κB.
Rompe, F., Artuc, M., Hallberg, A., Alterman, M., Stroeder, K., Thoene-Reineke, C., Reichenbach, A., Schacherl, J., Dahloef, B., Bader, M., Alenina, N., Schwaninger, M., Zuberbier, T., Funke-Kaiser, H., Schmidt, C., Schunck, W.H., Unger, T. and Steckelings, U.M.
Hypertension 55
(4): 924-931.
April 2010
Wnt signaling molecules in left ventricular remodeling. focus on dishevelled 1.
Zelarayan, L.C., Noack, C., Zafiriou, M.P., Renger, A. and Bergmann, M.W.
Hypertension 55
(4): 852-854.
April 2010
Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.
Heusser, K., Tank, J., Engeli, S., Diedrich, A., Menne, J., Eckert, S., Peters, T., Sweep, F.C., Haller, H., Pichlmaier, A.M., Luft, F.C. and Jordan, J.
Hypertension 55
(3): 619-626.
March 2010
Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.
Machnik, A., Dahlmann, A., Kopp, C., Goss, J., Wagner, H., van Rooijen, N., Eckardt, K.U., Mueller, D.N., Park, J.K., Luft, F.C., Kerjaschki, D. and Titze, J.
Hypertension 55
(3): 755-761.
March 2010
Aldosterone abrogates nuclear factor κB-mediated tumor necrosis factor α production in human neutrophils via the mineralocorticoid receptor.
Bergmann, A., Eulenberg, C., Wellner, M., Rolle, S., Luft, F.C. and Kettritz, R.
Hypertension 55
(2): 370-379.
February 2010
Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia.
Brosnihan, K.B., Hering, L., Dechend, R., Chappell, M.C. and Herse, F.
Hypertension 55
(2): 562-566.
February 2010
Metabolomics in angiotensin II-induced cardiac hypertrophy.
Mervaala, E., Biala, A., Merasto, S., Lempiaeinen, J., Mattila, I., Martonen, E., Eriksson, O., Louhelainen, M., Finckenberg, P., Kaheinen, P., Mueller, D.N., Luft, F.C., Lapatto, R. and Oresic, M.
Hypertension 55
(2): 508-515.
February 2010
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload.
Esposito, G., Perrino, C., Schiattarella, G.G., Belardo, L., di Pietro, E., Franzone, A., Capretti, G., Gargiulo, G., Pironti, G., Cannavo, A., Sannino, A., Izzo, R. and Chiariello, M.
Hypertension 55
(1): 137-143.
January 2010
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
Gomes, E.R., Lara, A.A., Almeida, P.W., Guimaraes, D., Resende, R.R., Campagnole-Santos, M.J., Bader, M., Santos, R.A. and Guatimosim, S.
Hypertension 55
(1): 153-160.
January 2010
2009
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats - role of endothelin-1.
Lamarca, B., Parrish, M., Ray, L.F., Murphy, S.R., Roberts, L., Glover, P., Wallukat, G., Wenzel, K., Cockrell, K., Martin, J.N., Ryan, M.J. and Dechend, R.
Hypertension 54
(4): 905-909.
October 2009
Immunology in hypertension, preeclampsia, and target-organ damage.
Verlohren, S., Mueller, D.N., Luft, F.C. and Dechend, R.
Hypertension 54
(3): 439-443.
September 2009
Growth arrest specific protein 6 participates in DOCA-induced target-organ damage.
Park, J.K., Theuer, S., Kirsch, T., Lindschau, C., Klinge, U., Heuser, A., Plehm, R., Todiras, M., Carmeliet, P., Haller, H., Luft, F.C., Mueller, D.N. and Fiebeler, A.
Hypertension 54
(2): 359-364.
August 2009
Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus.
Sugulle, M., Dechend, R., Herse, F., Weedon-Fekjaer, M.S., Johnsen, G.M., Brosnihan, K.B., Anton, L., Luft, F.C., Wollert, K.C., Kempf, T. and Staff, A.C.
Hypertension 54
(1): 106-112.
July 2009
Gitelman Syndrome.
Roser, M., Eibl, N., Eisenhaber, B., Seringer, J., Nagel, M., Nagorka, S., Luft, F.C., Frei, U. and Gollasch, M.
Hypertension 53
(6): 893-897.
June 2009
Cardiovascular regulation during apnea in elite divers.
Heusser, K., Dzamonja, G., Tank, J., Palada, I., Valic, Z., Bakovic, D., Obad, A., Ivancev, V., Breskovic, T., Diedrich, A., Joyner, M.J., Luft, F.C., Jordan, J. and Dujic, Z.
Hypertension 53
(4): 719-724.
April 2009
RALT specifically halts maladaptive cardiac hypertrophy. A new kid on the block.
Bergmann, M.W. and Zelarayan, L.
Hypertension 53
(3): 454-455.
March 2009
Energy metabolism in human renin-gene transgenic rats. Does renin contribute to obesity?
Gratze, P., Boschmann, M., Dechend, R., Qadri, F., Malchow, J., Graeske, S., Engeli, S., Janke, J., Springer, J., Contrepas, A., Plehm, R., Klaus, S., Nguyen, G., Luft, F.C. and Mueller, D.N.
Hypertension 53
(3): 516-523.
March 2009
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
Herse, F., Verlohren, S., Wenzel, K., Pape, J., Mueller, D.N., Modrow, S., Wallukat, G., Luft, F.C., Redman, C.W. and Dechend, R.
Hypertension 53
(2): 393-398.
February 2009
Functional characterization and transcriptome analysis of embryonic stem cell-derived contractile smooth muscle cells.
Potta, S.P., Liang, H., Pfannkuche, K., Winkler, J., Chen, S., Doss, M.X., Obernier, K., Kamisetti, N., Schulz, H., Huebner, N., Hescheler, J. and Sachinidis, A.
Hypertension 53
(2): 196-204.
February 2009
Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction.
da Costa Goncalves, A.C., Tank, J., Diedrich, A., Hilzendeger, A., Plehm, R., Bader, M., Luft, F.C., Jordan, J. and Gross, V.
Hypertension 53
(2): 387-392.
February 2009
2008
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor α in pregnant rats.
Lamarca, B., Wallukat, G., Llinas, M., Herse, F., Dechend, R. and Granger, J.P.
Hypertension 52
(6): 1168-1172.
December 2008
Cushing's disease, hypertension, and other sequels.
Singer, E., Strohm, S., Goebel, U., Bieringer, M., Schmidt, D., Schneider, W., Kettritz, R. and Luft, F.C.
Hypertension 52
(6): 1001-1005.
December 2008
Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.
Rentzsch, B., Todiras, M., Iliescu, R., Popova, E., Campos, L.A., Oliveira, M.L., Baltatu, O.C., Santos, R.A. and Bader, M.
Hypertension 52
(5): 967-973.
November 2008
Role of the multidomain protein spinophilin in blood pressure and cardiac function regulation.
da Costa-Goncalves, A.C., Tank, J., Plehm, R., Diedrich, A., Todiras, M., Gollasch, M., Heuser, A., Wellner, M., Bader, M., Jordan, J., Luft, F.C. and Gross, V.
Hypertension 52
(4): 702-707.
October 2008
Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes.
Dias-Peixoto, M.F., Santos, R.A., Gomes, E.R., Alves, M.N., Almeida, P.W., Greco, L., Rosa, M., Fauler, B., Bader, M., Alenina, N. and Guatimosim, S.
Hypertension 52
(3): 542-548.
September 2008
Treatment-sensitive premature renal and heart senescence in hypertension.
Bergmann, M.W., Zelarayan, L.C. and Gehrke, C.
Hypertension 52
(1): 61-62.
July 2008
Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mREN-2)27 rats.
Feldman, D.L., Jin, L., Xuan, H., Contrepas, A., Zhou, Y., Webb, R.L., Mueller, D.N., Feldt, S., Cumin, F., Maniara, W., Persohn, E., Schuetz, H., Jan Danser, A.H. and Nguyen, G.
Hypertension 52
(1): 130-136.
July 2008
Angiotensin-converting enzyme inhibition after experimental myocardial infarct: Role of the kinin B1 and B2 receptors.
Duka, A., Kintsurashvili, E., Duka, I., Ona, D., Hopkins, T.A., Bader, M., Gavras, I. and Gavras, H.
Hypertension 51
(5): 1352-1357.
May 2008
Deficiency of bradykinin receptor B2 is not detrimental in experimental stroke.
Kleinschnitz, C., Austinat, M., Bader, M., Renne, T. and Stoll, G.
Hypertension 51
(5): e41.
May 2008
Glucocorticoid-related signaling effects in vascular smooth muscle cells.
Molnar, G.A., Lindschau, C., Dubrovska, G., Mertens, P.R., Kirsch, T., Quinkler, M., Gollasch, M., Wresche, S., Luft, F.C., Mueller, D.N. and Fiebeler, A.
Hypertension 51
(5): 1372-1378.
May 2008
Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
Karatas, A., Hegner, B., de Windt, L.J., Luft, F.C., Schubert, C., Gross, V., Akashi, Y.J., Gürgen, D., Kintscher, U., da Costa Goncalves, A.C., Regitz-Zagrosek, V. and Dragun, D.
Hypertension 51
(4): 1177-1183.
April 2008
Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women.
Moldovanova, I., Schroeder, C., Jacob, G., Hiemke, C., Diedrich, A., Luft, F.C. and Jordan, J.
Hypertension 51
(4): 1203-1209.
April 2008
Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.
Feldt, S., Batenburg, W.W., Mazak, I., Maschke, U., Wellner, M., Kvakan, H., Dechend, R., Fiebeler, A., Burckle, C., Contrepas, A., Danser, A.H., Bader, M., Nguyen, G., Luft, F.C. and Mueller, D.N.
Hypertension 51
(3): 682-688.
March 2008
(Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in goldblatt rats.
Mueller, D.N., Klanke, B., Feldt, S., Cordasic, N., Hartner, A., Schmieder, R.E., Luft, F.C. and Hilgers, K.F.
Hypertension 51
(3): 676-681.
March 2008
ACE activity is modulated by kinin B2 receptor.
Sabatini, R.A., Guimaraes, P.B., Fernandes, L., Reis, F.C., Bersanetti, P.A., Mori, M.A., Navarro, A., Hilzendeger, A.M., Santos, E.L., Andrade, M.C., Chagas, J.R., Pesquero, J.L., Casarini, D.E., Bader, M., Carmona, A.K. and Pesquero, J.B.
Hypertension 51
(3): 689-695.
March 2008
Inversion region for hypertension and brachydactyly on chromosome 12p features multiple splicing and noncoding RNA.
Bähring, S., Kann, M., Neuenfeld, Y., Gong, M., Chitayat, D., Toka, H.R., Toka, O., Plessis, G., Maass, P., Rauch, A., Aydin, A. and Luft, F.C.
Hypertension 51
(2): 426-431.
February 2008
Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
Fischer, R., Dechend, R., Qadri, F., Markovic, M., Feldt, S., Herse, F., Park, J.K., Gapelyuk, A., Schwarz, I., Zacharzowsky, U.B., Plehm, R., Safak, E., Heuser, A., Schirdewan, A., Luft, F.C., Schunck, W.H. and Mueller, D.N.
Hypertension 51
(2): 540-546.
February 2008
Trophoblasts reduce the vascular smooth muscle cell proatherogenic response.
Hering, L., Herse, F., Verlohren, S., Park, J.K., Wellner, M., Qadri, F., Pijnenborg, R., Staff, A.C., Huppertz, B., Mueller, D.N., Luft, F.C. and Dechend, R.
Hypertension 51
(2): 554-559.
February 2008
Uterine vascular function in a transgenic preeclampsia rat model.
Verlohren, S., Niehoff, M., Hering, L., Geusens, N., Herse, F., Tintu, A.N., Plagemann, A., le Noble, F., Pijnenborg, R., Mueller, D.N., Luft, F.C., Dudenhausen, J.W., Gollasch, M. and Dechend, R.
Hypertension 51
(2): 547-553.
February 2008
Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice.
Xu, P., Costa-Goncalves, A.C., Todiras, M., Rabelo, L.A., Sampaio, W.O., Moura, M.M., Santos, S.S., Luft, F.C., Bader, M., Gross, V., Alenina, N. and Santos, R.A.S.
Hypertension 51
(2): 574-580.
February 2008
2007
Management of uncontrollable hypertension with a carotid sinus stimulation device.
Mohaupt, M.G., Schmidli, J. and Luft, F.C.
Hypertension 50
(5): 825-828.
November 2007
Yohimbine attenuates baroreflex-mediated bradycardia in humans.
Tank, J., Heusser, K., Diedrich, A., Brychta, R.J., Luft, F.C. and Jordan, J.
Hypertension 50
(5): 899-903.
November 2007
Response to questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia: There is no single universal preeclampsia cause.
Dechend, R.
Hypertension 50
: e4.
July 2007
Linking cardiac mechanosensing at the sarcomere M-band, nuclear factor kappaB signaling, and cardiac remodeling.
Bergmann, M.W. and de Windt, L.J.
Hypertension 49
(6): 1225-1227.
June 2007
Direct renin inhibition with aliskiren in obese patients with arterial hypertension.
Jordan, J., Engeli, S., Boye, S.W., Le Breton, S. and Keefe, D.L.
Hypertension 49
(5): 1047-1055.
May 2007
Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia.
Herse, F., Dechend, R., Harsem, N.K., Wallukat, G., Janke, J., Qadri, F., Hering, L., Mueller, D.N., Luft, F.C. and Staff, A.C.
Hypertension 49
(3): 604-611.
March 2007
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.
Hubel, C.A., Wallukat, G., Wolf, M., Herse, F., Rajakumar, A., Roberts, J.M., Markovic, N., Thadhani, R., Luft, F.C. and Dechend, R.
Hypertension 49
(3): 612-617.
March 2007
p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage.
Park, J.K., Fischer, R., Dechend, R., Shagdarsuren, E., Gapeljuk, A., Wellner, M., Meiners, S., Gratze, P., Al-Saadi, N., Feldt, S., Fiebeler, A., Madwed, J.B., Schirdewan, A., Haller, H., Luft, F.C. and Mueller, D.N.
Hypertension 49
(3): 481-489.
March 2007
Contribution of endothelial nitric oxide to blood pressure in humans.
Gamboa, A., Shibao, C., Diedrich, A., Choi, L., Pohar, B., Jordan, J., Paranjape, S., Farley, G. and Biaggioni, I.
Hypertension 49
(1): 170-177.
January 2007
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
Morecroft, I., Dempsie, Y., Bader, M., Walther, D.J., Kotnik, K., Loughlin, L., Nilsen, M. and Maclean, M.R.
Hypertension 49
(1): 232-236.
January 2007
2006
Influence of salt intake on renin-angiotensin and natriuretic peptide system genes in human adipose tissue.
Engeli, S., Boschmann, M., Frings, P., Beck, L., Janke, J., Titze, J., Luft, F.C., Heer, M. and Jordan, J.
Hypertension 48
(6): 1103-1108.
December 2006
Prorenin and its ancient receptor.
Burckle, C. and Bader, M.
Hypertension 48
(4): 549-551.
October 2006
Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans.
Mayer, A.F., Schroeder, C., Heusser, K., Tank, J., Diedrich, A., Schmieder, R.E., Luft, F.C. and Jordan, J.
Hypertension 48
(1): 120-126.
July 2006
Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats.
Titze, J., Luft, F.C., Bauer, K., Dietsch, P., Lang, R., Veelken, R., Wagner, H., Eckardt, K.U. and Hilgers, K.F.
Hypertension 47
(6): 1101-1107.
June 2006
Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor Mas knockout mice.
Santos, R.A., Castro, C.H., Gava, E., Pinheiro, S.V., Almeida, A.P., de Paula, R.D., Cruz, J.S., Ramos, A.S., Rosa, K.T., Irigoyen, M.C., Bader, M., Alenina, N., Kitten, G.T. and Ferreira, A.J.
Hypertension 547
(5): 996-1002.
May 2006
Matrix reloaded. The matrix metalloproteinase paradox.
Panek, A.N. and Bader, M.
Hypertension 47
(4): 640-641.
April 2006
Elevated blood pressure and heart rate in human renin receptor transgenic rats.
Burckle, C.A., Danser, A.H.J., Mueller, D.N., Garrelds, I.M., Gasc, J.M., Popova, E., Plehm, R., Peters, J., Bader, M. and Nguyen, G.
Hypertension 47
(3): 552-556.
March 2006
Novel integrative approaches to the identification of candidate genes in hypertension.
Hubner, N., Yagil, C. and Yagil, Y.
Hypertension 47
(1): 1-5.
January 2006
2005
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.
Walther, T., Wallukat, G., Jank, A., Bartel, S., Schultheiss, H.P., Faber, R. and Stepan, H.
Hypertension 46
(6): 1275-1279.
31 October 2005
Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart.
de Castro, C.H., Souza dos Santos, R.A., Ferreira, A.J., Bader, M., Alenina, N. and de Almeida, A.P.
Hypertension 46
(4): 937-942.
12 September 2005
Matrix-assisted laser desorption/ionization, time of flight, and angiotensin II.
Luft, F.C.
Hypertension 46
(3): 479-480.
22 August 2005
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
Pilz, B., Shagdarsuren, E., Wellner, M., Fiebeler, A., Dechend, R., Gratze, P., Meiners, S., Feldman, D.L., Webb, R.L., Garrelds, I.M., Danser, A.H.J., Luft, F.C. and Mueller, D.N.
Hypertension 46
(3): 569-576.
15 August 2005
Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives.
Boschmann, M., Engeli, S., Adams, F., Gorzelniak, K., Franke, G., Klaua, S., Kreuzberg, U., Luedtke, S., Kettritz, R., Sharma, A.M., Luft, F.C. and Jordan, J.
Hypertension 46
: 130-136.
1 July 2005
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia.
Dechend, R., Gratze, P., Wallukat, G., Shagdarsuren, E., Plehm, R., Braesen, J.H., Fiebeler, A., Schneider, W., Caluwaerts, S., Vercruysse, L., Pijnenborg, R., Luft, F.C. and Mueller, D.N.
Hypertension 45
(4): 742-746.
1 January 2005
Weight loss and the renin-angiotensin-aldosterone system.
Engeli, S., Boehnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F.C. and Sharma, A.M.
Hypertension 45
: 356-362.
1 January 2005
Baroreflex Failure.
Heusser, K., Tank, J., Luft, F.C. and Jordan, J.
Hypertension 45
: 834-839.
1 January 2005
Baroreflex regulation of heart rate and sympathetic vasomotor tone in women and men.
Tank, J., Diedrich, A., Szczech, E., Luft, F.C. and Jordan, J.
Hypertension 45
: 1159-1164.
1 January 2005
Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.
Xu, J., Carretero, O.A., Sun, Y., Shesely, E.G., Rhaleb, N.E., Liu, Y.H., Liao, T.D., Yang, J.J., Bader, M. and Yang, X.P.
Hypertension 45
(4): 747-753.
1 January 2005
2004
Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.
Pinheiro, S.V.B., Simoes e Silva, A.C., Sampaio, W.O., de Paula, R.D., Mendes, E.P., Bontempo, E.D., Pesquero, J.B., Walther, T., Alenina, N., Bader, M., Bleich, M. and Santos, R.A.S.
Hypertension 44
(4): 490-496.
1 October 2004
Oxidative stress and preeclampsia. Rationale for antioxidant clinical trials.
Raijmakers, M.T., Dechend, R. and Poston, L.
Hypertension 44
: 374-380.
23 August 2004
Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries.
Verlohren, S., Dubrovska, G., Tsang, S.Y., Essin, K., Luft, F.C., Huang, Y. and Gollasch, M.
Hypertension 44
(3): 271-276.
9 August 2004
Geneticism of essential hypertension.
Luft, F.C.
Hypertension 43
(6): 1155-1159.
June 2004
Obesity and hypertension-induced restrictive cardiomyopathy - A harbinger of things to come.
Pilz, B., Braesen, J.H., Schneider, W. and Luft, F.C.
Hypertension 43
(5): 911-917.
1 May 2004
α-2 adrenergic transmission and human baroreflex regulation.
Tank, J., Diedrich, A., Szczech, E., Luft, F.C. and Jordan, J.
Hypertension 43
(5): 1035-1041.
1 May 2004
Clonidine improves spontaneous baroreflex sensitivity in conscious mice through parasympathetic activation.
Tank, J., Jordan, J., Diedrich, A., Obst, M., Plehm, R., Luft, F.C. and Gross, V.
Hypertension 43
(5): 1042-1047.
May 2004
Alterations in sympathetic ganglionic transmission in response to angiotensin II in (mRen2)27 transgenic rats.
Aileru, A.A., Logan, E., Callahan, M., Ferrario, C.M., Ganten, D. and Diz, D.I.
Hypertension 43
(2): 270-275.
February 2004
Autosomal-dominant hypertension with type E brachydactyly is caused by rearrangement on the short arm of chromosome 12.
Bähring, S., Rauch, A., Toka, O., Schroeder, C., Hesse, C., Siedler, H., Fesues, G., Haefeli, W.E., Busjahn, A., Aydin, A., Neuenfeld, Y., Muehl, A., Toka, H.R., Gollasch, M., Jordan, J. and Luft, F.C.
Hypertension 43
(2): 471-476.
February 2004
Forced homodimerization by site-directed mutagenesis alters guanylyl cyclase activity of natriuretic peptide receptor B.
Langenickel, T., Buttgereit, J., Pagel, I., Dietz, R., Willenbrock, R. and Bader, M.
Hypertension 43
(2): 460-465.
February 2004
2003
Glucose-induced TGF-β 1 and TGF-β receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-α.
Lindschau, C., Quass, P., Menne, J., Guler, F., Fiebeler, A., Leitges, M., Luft, F.C. and Haller, H.
Hypertension 42
(3): 335-341.
September 2003
Pressor effect of water drinking in tetraplegic patients may be a spinal reflex.
Tank, J., Schroeder, C., Stoffels, M., Diedrich, A., Sharma, A.M., Luft, F.C. and Jordan, J.
Hypertension 41
(6): 1234-1239.
June 2003
Exercising restraint in measuring blood pressure in conscious mice.
Gross, V. and Luft, F.C.
Hypertension 41
(4): 879-881.
April 2003
The role of Wnk4 in polygenic hypertension - A candidate gene analysis on rat chromosome 10.
Monti, J., Zimdahl, H., Schulz, H., Plehm, R., Ganten, D. and Hübner, N.
Hypertension 41
(4): 938-942.
April 2003
Abolition of end-organ damage by antiandrogen treatment in female hypertensive transgenic rats.
Baltatu, O., Cayla, C., Iliescu, R., Andreev, D. and Bader, M.
Hypertension 41
(3): 830-833.
March 2003
Delayed maturation of catecholamine phenotype in nucleus tractus solitarius of rats with glial angiotensinogen depletion.
Ogier, M., Bezin, L., Cottet-Emard, J.M., Bader, M., Vincent, M., Pequignot, J.M., McGregor, J. and Bricca, G.
Hypertension 42
(5): 978-984.
1 January 2003
Tissue-specific response to interstitial angiotensin II in humans.
Boschmann, M., Jordan, J., Adams, F., Christensen, N.J., Tank, J., Franke, G., Stoffels, M., Sharma, A.M., Luft, F.C. and Klaus, S.
Hypertension 41
(1): 37-41.
January 2003
2002
Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage.
Muller, D.N., Mullally, A., Dechend, R., Park, J.K., Fiebeler, A., Pilz, B., Loeffler, B.M., Blum-Kaelin, D., Masur, S., Dehmlow, H., Aebi, J.D., Haller, H. and Luft, F.C.
Hypertension 40
(6): 840-846.
December 2002
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Sharma, A.M., Janke, E., Gorzelniak, K., Engeli, S. and Luft, F.C.
Hypertension 40
(5): 609-611.
1 November 2002
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
Kaergel, E., Mueller, D.N., Honeck, H., Theuer, J., Shagdarsuren, E., Mullally, A., Luft, F.C. and Schunck, W.H.
Hypertension 40
(3): 273-279.
1 September 2002
Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure.
Busjahn, A., Aydin, A., Uhlmann, R., Krasko, C., Bähring, S., Szelestei, T., Feng, Y., Dahm, S., Sharma, A.M., Luft, F.C. and Lang, F.
Hypertension 40
(3): 256-260.
September 2002
Heart rate variability and baroreflex function in AT2 receptor-disrupted mice.
Gross, V., Plehm, R., Tank, J., Jordan, J., Diedrich, A., Obst, M. and Luft, F.C.
Hypertension 40
(2): 207-213.
August 2002
Conserved synteny in rat and mouse for a blood pressure QTL on human chromosome 17.
Zimdahl, H., Kreitler, T., Gösele, C., Ganten, D. and Hübner, N.
Hypertension 39
(6): 1050-1052.
1 June 2002
Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection.
Phillips, M.I., Tang, Y., Schmidt-Ott, K., Qian, K. and Kagiyama, S.
Hypertension 39
(2 Pt 2): 651-655.
February 2002
Expression of human angiotensinogen-renin in rat - effects on transcription and heart function.
Bartel, S., Hoch, B., Vetter, D. and Krause, E.G.
Hypertension 39
(2): 219-223.
1 January 2002
Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity.
Jordan, J., Shannon, J.R., Diedrich, A., Black, B.K. and Robertson, D.
Hypertension 39
(1): 173-178.
1 January 2002
Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators.
Lauterbach, B., Barbosa-Sicard, E., Wang, M.H., Honeck, H., Kaergel, E., Theuer, J., Schwartzman, M.L., Haller, H., Luft, F.C., Gollasch, M. and Schunck, W.H.
Hypertension 39
(2): 609-613.
1 January 2002
Tonin and kallikrein in the brain of transgenic rat line expressing human tissue kallikrein.
Lomez, E.S.L., Araujo, R.C., Bader, M., Pesquero, J.B. and Pesquero, J.L.
Hypertension 39
: 229-232.
1 January 2002
Cardiac and renal effects of growth hormone in volume overload-induced heart failure - Role of NO.
Pagel, I., Langenickel, T., Hohnel, K., Philipp, S., Nussler, A.K., Blum, W.F., Aubert, M.L., Dietz, R. and Willenbrock, R.
Hypertension 39
: 57-62.
1 January 2002
Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury.
Park, J.K., Fiebeler, A., Muller, D.N., Mervaala, E.M.A., Dechend, R., Abou-Rebyeh, F., Luft, F.C. and Haller, H.
Hypertension 39
: 685-689.
1 January 2002
2001
Renin uptake by the endothelium mediates vascular angiotensin formation.
Hilgers, K.F., Veelken, R., Mueller, D.N., Kohler, H., Hartner, A., Botkin, S.R., Stumpf, C., Schmieder, R.E. and Gomez, R.A.
Hypertension 38
: 243-248.
August 2001
Do beta-blockers put on weight?
Kumpusalo, E.A. and Takala, J.K.
Hypertension 38
: E4-E5.
1 July 2001
beta-Adrenergic receptor blockers and weight gain - A systematic analysis.
Sharma, A.M., Pischon, T., Hardt, S., Kunz, I. and Luft, F.C.
Hypertension 37
: 250-254.
1 February 2001
Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen.
Baltatu, O., Janssen, B.J., Bricca, G., Plehm, R., Monti, J., Ganten, D. and Bader, M.
Hypertension 37
(2): 408-413.
1 January 2001
Enhanced affective startle modulation in salt-sensitive subjects.
Buchholz, K., Schaechinger, H., Wagner, M., Schorr, U., Sharma, A.M. and Deter, H.C.
Hypertension 38
: 1325-1329.
1 January 2001
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
Cheng, Z.J., Vaskonen, T., Tikkanen, I., Nurminen, K., Ruskoaho, H., Vapaatalo, H., Muller, D., Park, J.K., Luft, F.C. and Mervaala, E.M.A.
Hypertension 37
: 433-439.
1 January 2001
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury.
Fiebeler, A., Schmidt, F., Mueller, D.N., Park, J.K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H. and Luft, F.C.
Hypertension 37
: 787-793.
1 January 2001
Neurovascular contact of cranial nerve IX and X root-entry zone in hypertensive patients.
Hohenbleicher, H., Schmitz, S.A., Koennecke, H.C., Offermann, R., Offermann, J., Zeytountchian, H., Wolf, K.J., Distler, A. and Sharma, A.M.
Hypertension 37
: 176-181.
1 January 2001
Responses to central Na+ and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen.
Huang, B.S., Ganten, D. and Leenen, F.H.H.
Hypertension 37
(2): 683-686.
1 January 2001
Mechanisms and cardiovascular damage in hypertension.
Luft, F.C.
Hypertension 37
: 594-598.
1 January 2001
Twins in cardiovascular genetic research.
Luft, F.C.
Hypertension 37
: 350-356.
1 January 2001
Peaks and valleys.
Luft, F.C. and Busjahn, A.
Hypertension 38
: 38-40.
1 January 2001
Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.
Mervaala, E.M.A., Cheng, Z.J., Tikkanen, I., Lapatto, R., Nurminen, K., Vapaatalo, H., Mueller, D.N., Fiebeler, A., Ganten, U., Ganten, D. and Luft, F.C.
Hypertension 37
(2): 414-418.
1 January 2001
Normal blood pressure and renal function in mice lacking the bradykinin B2 receptor.
Milia, A.F., Gross, V., Plehm, R., De Silva, J.A., Bader, M. and Luft, F.C.
Hypertension 37
: 1473-1479.
1 January 2001
Expression analysis using oligonucleotide microarrays in mice lacking bradykinin type 2 receptors.
Monti, J., Gross, V., Luft, F.C., Milia, A.F., Schulz, H., Dietz, R., Sharma, A.M. and Hübner, N.
Hypertension 38
(1): E1-E3.
1 January 2001
Neurovascular contact of cranial nerve IX and X root-entry zone in hypertensive patients - Response.
Sharma, A.M. and Hohenbleicher, H.
Hypertension 37
: E25-E26.
1 January 2001
Limited effect of systemic beta-blockade on sympathetic outflow.
Tank, J., Diedrich, A., Schroeder, C., Stoffels, M., Franke, G., Sharma, A.M., Luft, F.C. and Jordan, J.
Hypertension 38
: 1377-1381.
1 January 2001
Genetic influences on baroreflex function in normal twins.
Tank, J., Jordan, J., Diedrich, A., Stoffels, M., Franke, G., Faulhaber, H.D., Luft, F.C. and Busjahn, A.
Hypertension 37
: 907-910.
1 January 2001
ACE D/I polymorphism and incidence of post-PTCA restenosis - A prospective, angiography-based evaluation.
Zee, R.Y.L., Fernandez-Ortiz, A., Macaya, C., Pintor, E., Lindpaintner, K. and Fernandez-Cruz, A.
Hypertension 37
(3): 851-855.
1 January 2001
Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.
dos Santos, R.A.S., Passaglio, K.T., Pesquero, J.B., Bader, M. and Silva, A.C.S.E.
Hypertension 38
: 660-664.
1 January 2001
2000
Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.
Honeck, H., Gross, V., Erdmann, B., Kaergel, E., Neunaber, R., Milia, A.F., Schneider, W., Luft, F.C. and Schunck, W.H.
Hypertension 36
: 610-616.
1 October 2000
Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries.
Matrougui, K., Eskildsen-Helmond, Y.E.G., Fiebeler, A., Henrion, D., Levy, B.I., Tedgui, A. and Mulvany, M.J.
Hypertension 36
: 617-621.
1 October 2000
Interaction of carbon dioxide and sympathetic nervous system activity in the regulation of cerebral perfusion in humans.
Jordan, J., Shannon, J.R., Diedrich, A., Black, B., Costa, F., Robertson, D. and Biaggioni, I.
Hypertension 36
: 383-388.
1 September 2000
Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
Muller, D.N., Mervaala, E.M.A., Schmidt, F., Park, J.K., Dechend, R., Genersch, E., Breu, V., Loeffler, B.M., Ganten, D., Schneider, W., Haller, H. and Luft, F.C.
Hypertension 36
(2): 282-290.
1 August 2000
Resting metabolic rate and substrate use in obesity hypertension.
Kunz, I., Schorr, U., Klaus, S. and Sharma, A.M.
Hypertension 36
: 26-32.
1 July 2000
Physiology and pathophysiology of the adipose tissue renin-angiotensin system.
Engeli, S., Negrel, R. and Sharma, A.M.
Hypertension 35
(6): 1270-1277.
1 June 2000
Synergistic effects of AT1 and ETA receptor blockade in a transgenic, angiotensin II-dependent, rat model.
Bohlender, J., Gerbaulet, S., Kraemer, J., Gross, M., Kirchengast, M. and Dietz, R.
Hypertension 35
(4): 992-997.
1 April 2000
Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Mervaalo, E., Mueller, D.N., Schmidt, F., Park, J.K., Gross, V., Bader, M., Breu, V., Ganten, D., Haller, H. and Luft, F.C.
Hypertension 35
(2): 587-594.
1 February 2000
The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy.
Baltatu, O., Silva, J.A., Ganten, D. and Bader, M.
Hypertension 35
(1): 409-412.
1 January 2000
Angiotensinogen concentrations and renin clearance. Implications for blood pressure regulation.
Bohlender, J., Menard, J., Ganten, D. and Luft, F.C.
Hypertension 35
: 780-786.
1 January 2000
beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins.
Busjahn, A., Li, G.H., Faulhaber, H.D., Rosenthal, M., Becker, A., Jeschke, E., Schuster, H., Timmermann, B., Hoehe, M.R. and Luft, F.C.
Hypertension 35
: 555-560.
1 January 2000
Vasopressin and blood pressure in humans.
Jordan, J., Tank, J., Diedrich, A., Robertson, D. and Shannon, J.R.
Hypertension 36
: E3-E4.
1 January 2000
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Mervaala, E., Mueller, D.N., Park, J.K., Dechend, R., Schmidt, F., Fiebeler, A., Bieringer, M., Breu, V., Ganten, D., Haller, H. and Luft, F.C.
Hypertension 35
(1): 360-366.
1 January 2000
NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats.
Muller, D.N., Dechend, R., Mervaala, E.M.A., Park, J.K., Schmidt, F., Fiebeler, A., Theuer, J., Breu, V., Ganten, D., Haller, H. and Luft, F.C.
Hypertension 35
(1): 193-201.
1 January 2000
1999
beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.
Gratze, G., Fortin, J., Labugger, R., Binder, A., Kotanko, P., Timmermann, B., Luft, F.C., Hoehe, M.R. and Skrabal, F.
Hypertension 33
: 1425-1430.
1 June 1999
Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib pairs.
Niu, T.H., Xu, X.P., Cordell, H.J., Rogus, J., Zhou, Y.S., Fang, Z. and Lindpaintner, K.
Hypertension 33
: 1332-1337.
1 June 1999
Angiotensinogen gene polymorphisms M235T/T174M - No excess transmission to hypertensive Chinese.
Niu, T.H., Yang, J.H., Wang, B.Y., Chen, W., Wang, Z.X., Laird, N., Wei, E., Fang, Z., Lindpaintner, K., Rogus, J.J. and Xu, X.P.
Hypertension 33
: 698-702.
1 February 1999
Increased central angiotensin and osmotic responses in the Ren-2 transgenic rat.
Nishioka, T., Callahan, M.F., Li, P., Ferrario, C.M., Ganten, D. and Morris, M.
Hypertension 33
: 385-388.
11 January 1999
Congenic substitution mapping excludes Sa as a candidate gene locus for a blood pressure quantitative trait locus on rat chromosome 1.
Hübner, N., Lee, Y.A., Lindpaintner, K., Ganten, D. and Kreutz, R.
Hypertension 34
: 643-648.
1 January 1999
Hypertension-induced end-organ damage - A new transgenic approach to an old problem.
Luft, F.C., Mervaala, E., Mueller, D.N., Gross, V., Schmidt, F., Park, J.K., Schmitz, C., Lippoldt, A., Breu, V., Dechend, R., Dragun, D., Schneider, W., Ganten, D. and Haller, H.
Hypertension 33
: 212-218.
1 January 1999
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.
Mervaala, E.M.A., Mueller, D.N., Park, J.K., Schmidt, F., Loehn, M., Breu, V., Dragun, D., Ganten, D., Haller, H. and Luft, F.C.
Hypertension 33
: 389-395.
1 January 1999
Effects of human prorenin in rats transgenic for human angiotensinogen.
Mueller, D.N., Hilgers, K.F., Mathews, S., Breu, V., Fischli, W., Uhlmann, R. and Luft, F.C.
Hypertension 33
: 312-317.
1 January 1999
Transcriptional regulation of the rat renin gene by regulatory elements in intron I.
Voigtlaender, T., Ganten, D. and Bader, M.
Hypertension 33
: 303-311.
1 January 1999
Role of chromosome X in the Sabra rat model of salt-sensitive hypertension.
Yagil, C., Sapojnikov, M., Kreutz, R., Zuercher, H., Ganten, D. and Yagil, Y.
Hypertension 33
: 261-265.
1 January 1999
1998
Raised cerebrovascular resistance in idiopathic orthostatic intolerance: evidence for sympathetic vasoconstriction.
Jordan, J., Shannon, J.R., Black, B.K., Paranjape, S.Y., Barwise, J. and Robertson, D.
Hypertension 32
: 699-704.
1 October 1998
Renovascular hypertension in bradykinin B2-receptor knockout mice.
Madeddu, P., Milia, A.F., Salis, M.B., Gaspa, L., Gross, W., Lippoldt, A. and Emanueli, C.
Hypertension 32
: 503-509.
1 September 1998
Converting enzyme determines plasma clearance of angiotensin-(1-7).
Yamada, K., Iyer, S.N., Chappell, M.C., Ganten, D. and Ferrario, C.M.
Hypertension 32
(3): 496-502.
1 September 1998
Uncoupling of the baroreflex by NN-cholinergic blockade in dissecting the components of cardiovascular regulation.
Shannon, J.R., Jordan, J., Black, B.K., Costa, F. and Robertson, D.
Hypertension 32
: 101-107.
1 July 1998
NN-nicotinic blockade as an acute human model of autonomic failure.
Jordan, J., Shannon, J.R., Black, B.K., Lance, R.H., Squillante, M.D., Costa, F. and Robertson, D.
Hypertension 31
: 1178-1184.
1 May 1998
Evaluation of the angiotensinogen locus in human essential hypertension: A European study.
Brand, E., Chatelain, N., Keavney, B., Caulfield, M., Citterio, L., Connell, J., Grobbee, D., Schmidt, S., Schunkert, H., Schuster, H., Sharma, A.M. and Soubrier, F.
Hypertension 31
(3): 725-729.
1 March 1998
NK1 receptor antagonist blocks angiotensin II responses in renin transgenic rat medulla oblongata.
Diz, D.I., Westwood, B., Bosch, S.M., Ganten, D. and Ferrario, C.M.
Hypertension 31
: 473-479.
1 January 1998
Angiotensinases restrict locally generated angiotensin II to the blood vessel wall.
Hilgers, K.F., Bingener, E., Stumpf, C., Muller, D.N., Schmieder, R.E. and Veelken, R.
Hypertension 31
: 368-372.
1 January 1998
Salt susceptibility maps to chromosomes 1 and 17 with sex specificity in the Sabra rat model of hypertension.
Yagil, C., Sapojnikov, M., Kreutz, R., Katni, G., Lindpaintner, K., Ganten, D. and Yagil, Y.
Hypertension 31
: 119-124.
1 January 1998
Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: A pharmacogenetic analysis.
Zee, R.Y.L., Rao, V.S., Paster, R.Z., Sweet, C.S. and Lindpaintner, K.
Hypertension 31
: 925-928.
1 January 1998
1997
Malignant vagotonia due to selective baroreflex failure.
Jordan, J., Shannon, J.R., Black, B.K., Costa, F., Ertl, A.C., Furlan, R., Biaggioni, I. and Robertson, D.
Hypertension 30
: 1072-1077.
1 November 1997
The hypertension of autonomic failure and its treatment.
Shannon, J.R., Jordan, J., Costa, F., Robertson, R.M. and Biaggioni, I.
Hypertension 30
: 1062-1067.
1 November 1997
Enalapril and renal function in hypertensive rats transgenic for mouse renin gene.
Springate, J.E., Feld, L.G. and Ganten, D.
Hypertension 30
: 868-872.
1 October 1997
High human renin hypertension in transgenic rats.
Bohlender, J., Fukamizu, A., Lippoldt, A., Nomura, T., Dietz, R., Menard, J., Murakami, K., Luft, F.C. and Ganten, D.
Hypertension 29
(1 Pt 2): 428-434.
1 January 1997
Dose effects of human renin in rats transgenic for human angiotensiogen.
Bohlender, J., Menard, J., Luft, F.C. and Ganten, D.
Hypertension 291
: 1031-1038.
1 January 1997
Angiotensin converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions: a twin study.
Busjahn, A., Knoblauch, H., Knoblauch, M., Bohlender, J., Menz, M., Faulhaber, H.D., Becker, A., Schuster, H. and Luft, F.C.
Hypertension 29
(1 Pt 2): 165-170.
1 January 1997
Hypothalamic substance P release: attenuated angiotensin responses in mRen2(27) transgenic rats.
Diz, D.I., Falgui, B., Bosch, S.M., Westwood, B., Kent, J., Ganten, D. and Ferrario, C.M.
Hypertension 29
: 510-513.
1 January 1997
Pressure natriuresis in salt sensitive and salt resistant sabra rats.
Gross, V., Lippoldt, A., Yagil, C., Yagil, Y. and Luft, F.C.
Hypertension 29
: 1252-1259.
1 January 1997
Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients.
Haller, H., Ziegler, E.M., Homuth, V., Drab, M., Eichhorn, J., Nagy, Z., Busjahn, A., Vetter, K. and Luft, F.C.
Hypertension 29
: 291-296.
1 January 1997
Role of the alpha, beta, and gamma subunits of epithelial sodium channel in a model of polygenic hypertension.
Kreutz, R., Struk, B., Rubattu, S., Hübner, N., Szpirer, J., Szpirer, C., Ganten, D. and Lindpaintner, K.
Hypertension 29
: 131-136.
1 January 1997
Nitric oxide synthase and renin angiotensin system gene expression in salt-sensitive and salt-resistant Sabra rats.
Lippoldt, A., Gross, V., Schneider, K., Hansson, A.C., Nadaud, S., Schneider, W., Bader, M., Yagil, S.A., Yagil, J. and Luft, F.C.
Hypertension 30
: 409-415.
1 January 1997
alpha1-adrenergic receptor antibodies in patients with primary hypertension.
Luther, H.P., Homuth, V. and Wallukat, G.
Hypertension 29
: 678-682.
1 January 1997
Vascular angiotensin converting enzyme expression regulates local angiotensin II.
Mueller, D.N., Bohlender, J., Hilgers, K.F., Dragun, D., Costerousse, O., Menard, J. and Luft, F.C.
Hypertension 29
(1 Pt 1): 98-104.
1 January 1997
1996
The Y chromosome. Epistatic and ecogenetic interactions in genetic hypertension.
Kreutz, R., Stock, P., Struk, B. and Lindpaintner, K.
Hypertension 28
: 895-897.
1 November 1996
Role of area postrema in transgene hypertension.
Averill, D., Matsumura, K., Ganten, D. and Ferrario, C.M.
Hypertension 27
: 591-597.
1 January 1996
Human renin-dependent hypertension in rats transgenic for human angiotensinogen.
Bohlender, J., Menard, J., Wagner, J., Luft, F.C. and Ganten, D.
Hypertension 27
: 535-540.
1 January 1996
Salt sensitive hypertension in (mREN-2)27 transgenic rats.
Callahan, M.F., Ping, L., Ferrario, C.M., Ganten, D. and Morris, M.
Hypertension 27
: 573-577.
1 January 1996
Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex.
Erdmann, B., Fuxe, K. and Ganten, D.
Hypertension 28
: 818-824.
1 January 1996
Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat.
Marttila, M., Vuolteenaho, O., Ganten, D., Nakao, K. and Ruskoaho, H.
Hypertension 28
: 995-1004.
1 January 1996
Role of angiotensin converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development.
Ohta, K., Kim, S. and Iwao, H.
Hypertension 28
: 627-634.
1 January 1996
Permanent inhibition of angiotensinogen synthesis by antisense RNA expression.
Schinke, M., Boehm, M., Bricca, G., Ganten, D. and Bader, M.
Hypertension 27
: 508-513.
1 January 1996
Autosomal dominant hypertension and brachydactyly in a turkish kindred resembles essential hypertension.
Schuster, H., Wienker, T.F., Toka, H.R., Bähring, S., Jeschke, E., Toka, O., Busjahn, A., Hempel, A., Tahlhammer, C., Oelkers, W., Kunze, J., Bilginturan, N., Haller, H. and Luft, F.C.
Hypertension 28
: 1085-1092.
1 January 1996
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock, R., Scheuermann, M., Hohnel, K., Luft, F.C. and Dietz, R.
Hypertension 27
(6): 1259-1266.
1 January 1996
1995
Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats.
Moriguchi, A., Tallant, E.A., Matsumura, K., Reilly, T.M., Walton, H., Ganten, D. and Ferrario, C.M.
Hypertension 25
(6): 1260-1265.
1 June 1995
Angiotensin and bradykinin peptides in the TGR(mREN-2)27 rat.
Campbell, D.J., Rong, P., Kladis, A., Rees, B., Ganten, D. and Skinner, S.L.
Hypertension 25
(5): 1014-1020.
1 May 1995
Effect of captopril and angiotensin II receptor blockade on pressure natriuresis in transgenic TGR(mRen-2)27 rats.
Gross, V., Lippoldt, A., Schneider, W. and Luft, F.C.
Hypertension 26
(3): 471-479.
1 January 1995
Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats.
Haller, H., Behrend, M., Park, J.K., Schaberg, T., Luft, F.C. and Distler, A.
Hypertension 25
: 132-138.
1 January 1995
Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells.
Haller, H., Schaper, D., Ziegler, W., Philipp, S., Kuhlmann, M., Distler, A. and Luft, F.C.
Hypertension 25
: 511-516.
1 January 1995
Transforming growth factor beta1 expression and phenotypic modulation in the kidney of hypertensive rats.
Hamaguchi, A., Kim, S., Ohta, K., Yagi, K., Yukimura, T., Miura, K., Fukuda, T. and Iwao, H.
Hypertension 26
: 199-207.
1 January 1995
Altered angiotensinogen amino acid sequence and plasma angiotensin II levels in genetically hypertensive rats: a study on cause and effects.
Huebner, N., Kreutz, R., Takahashi, S., Ganten, D. and Lindpaintner, K.
Hypertension 26
: 279-284.
1 January 1995
Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats.
Kim, S.K., Ohta, K., Hamaguchi, A., Yukimura, T., Miura, K. and Iwao, H.
Hypertension 25
: 1252-1259.
1 January 1995
Investigation of the phenylethanolamine N-Methyltransferase gene as a candidate gene for hypertension.
Koike, G., Jacob, H.J., Krieger, J.E., Szpirer, C., Hoehe, M.R., Horiuchi, M. and Dzau, V.J.
Hypertension 26
: 595-601.
1 January 1995
Gene expression of brain nitric oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats.
Krukoff, T.L., Gehlen, F., Ganten, D. and Wagner, J.
Hypertension 26
: 171-176.
1 January 1995
Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
Lee, M.A., Boehm, M., Kim, S., Bachmann, S., Bachmann, J., Bader, M. and Ganten, D.
Hypertension 25
: 570-580.
1 January 1995
Expression of angiotensin-converting enzype in renovascular hypertensive rat kidney.
Mai, M., Hilgers, K.F., Wagner, J., Mann, J.F.E. and Geiger, H.
Hypertension 25
: 674-678.
1 January 1995
Effects of human renin in the vasculature of rats transgenic for human angiotensinogen.
Mueller, D.N., Hilgers, K.F., Bohlender, J., Lippoldt, A., Wagner, J., Fischli, W., Ganten, D., Mann, J.F.E. and Luft, F.C.
Hypertension 26
: 272-278.
1 January 1995
Characterization and functional analysis of the rat endothelin-1 promoter.
Paul, M., Zintz, M., Boecker, W. and Dyer, M.
Hypertension 25
: 683-687.
1 January 1995
Effects of bromocriptine on cardiovascular regulation in healthy humans.
Schobel, H.P., Schmieder, R.E., Hartmann, S., Schachinger, H. and Luft, F.C.
Hypertension 25
(5): 1075-1082.
1 January 1995
1994
Platelet-derived growth factor and angiotensin II induce different spatial distribution of protein kinase C-alpha and -beta in vascular smooth muscle cells.
Haller, H., Quass, P., Lindschau, C., Luft, F.C. and Distler, A.
Hypertension 23
(6 Pt 2): 848-852.
1 June 1994
Unlike human hypertension, blood pressure in a hereditary hypertensive rat strain shows no linkage to the angiotensinogen locus.
Hübner, N., Kreutz, R., Takahashi, S., Ganten, D. and Lindpaintner, K.
Hypertension 23
(6 Pt 1): 797-801.
1 June 1994
beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.
Boehm, M., Moll, M., Schmid, B., Paul, M., Ganten, D., Castellano, M. and Erdmann, E.
Hypertension 24
: 653-662.
1 January 1994
Differential regulation of vascular angiotensin I-converting enzyme in hypertension.
Fernandez-Alfonso, M.S., Kreutz, R., Zeh, K., Liu, Y., Ganten, D. and Paul, M.
Hypertension 24
: 280-286.
1 January 1994
Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene.
Hirth-Dietrich, C., Stasch, J.P., Ganten, D. and Luft, F.C.
Hypertension 23
: 626-631.
1 January 1994
Mechanism by which angiotensin II stabilizes messenger RNA for angiotensinogen.
Klett, C., Bader, M., Ganten, D. and Hackenthal, E.
Hypertension 23
: I120-I125.
1 January 1994
Caveat emptor.
Lindpaintner, K. and Kreutz, R.
Hypertension 24
: 251-253.
1 January 1994
Sympathetic baroreceptor responses after chronic NG-Nitro-L- Arginine methyl ester treatment in conscious rats.
Scrogin, K., Veelken, R. and Luft, F.C.
Hypertension 23
: 982-986.
1 January 1994
Increased cytosolic sodium and reduced Na,K-ATPase activity in transgenic rats.
Tepel, M., Theilmeier, G., Bachmann, J., Barenbrock, M., Spieker, C., Ganten, D., Rahn, K.H. and Zidek, W.
Hypertension 23, Suppl. I
: I-198-I-202.
1 January 1994
Impaired cardiovascular reflexes precede desoxycorticosterone acetate-salt hypertension.
Veelken, R., Hilgers, K.F., Ditting, T., Leonard, M., Mann, J.F., Geiger, H. and Luft, F.C.
Hypertension 24
: 564-570.
1 January 1994
1993
Early interstitial changes in hypertension-induced renal injury.
Mai, M., Geiger, H., Hilgers, K.F., Veelken, R., Mann, J.F., Dammrich, J. and Luft, F.C.
Hypertension 22
(5): 754-765.
1 November 1993
Circadian blood pressure variation in transgenic hypertensive rats.
Lemmer, B., Mattes, A., Boehm, M. and Ganten, D.
Hypertension 22
(1): 97-101.
July 1993
Angiotensinogen is cleaved to angiotensin in isolated rat blood vessels.
Hilgers, K.F., Hilgenfeldt, U., Veelken, R., Muley, T., Ganten, D., Luft, F.C. and Mann, J.F.
Hypertension 21
: 1030-1034.
1 January 1993
Angiotensin II facilitates sympathetic transmission in rat hind limb circulation.
Hilgers, K.F., Veelken, R., Rupprecht, G., Reeh, P.W., Luft, F.C. and Mann, J.F.
Hypertension 21
: 322-328.
1 January 1993
Volhard, Franz in historical perspective.
Luft, F.C. and Dietz, R.
Hypertension 22
: 253-256.
1 January 1993
1992
Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
Bader, M., Zhao, Y., Sander, M., Lee, M.A., Bachmann, J., Boehm, M., Djavidani, B., Peters, J., Mullins, J.J. and Ganten, D.
Hypertension 19
(6 Pt 2): 681-686.
1 June 1992
Increased vascular angiotensin formation in female rats harboring the mouse ren-2 gene.
Hilgers, K.F., Peters, J., Veelken, R., Sommer, M., Rupprecht, G., Ganten, D., Luft, F.C. and Mann, J.F.
Hypertension 19
(6 Pt 2): 687-691.
1 June 1992
Genetic variation in hypertensive and control strains - what are we controlling for anyway (editorial).
Lindpaintner, K., Kreutz, R. and Ganten, D.
Hypertension 19
: 428-430.
1 January 1992
1991
Transgenic rats: new animal models in hypertension research. Invited lecture.
Ganten, D., Lindpaintner, K., Ganten, U., Peters, J., Zimmermann, F., Bader, M. and Mullins, J.J.
Hypertension 17
: 843-855.
1 January 1991
Genetic basis of hypertension.
Ganten, D., Takahashi, S., Lindpaintner, K. and Mullins, J.J.
Hypertension 18
: III109-III114.
1 January 1991
1984
Dedication. Professor Franz Gross, 1913 - 1984.
Ganten, D.
Hypertension 6
(3): i-ii.
May 1984
This list was generated on Mon Nov 11 17:05:06 2024 UTC.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
